Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

www.MarketResearchReports.com

PharmaPoint: Prophylactic Human

Papillomavirus Vaccines - Global

Drug Forecast and Market Analysis to

2022

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

http://www.marketresearchreports.com/


Introduction to Report

Launch Date: March 31, 2014

Number of Pages: 188

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 9,995

Price For Site License: USD 1,990

Price For Global User License: USD 29,985

Delivery Time: Within 24 Hours (During Working Days)



About the Report

The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV vaccines were developed and marketed solely to protect against cervical cancer.

In recent years the role of HPV in other cancers has been increasingly recognized which has facilitated a shift towards vaccinating a wider population, most significant has been the inclusion of males in routine vaccine recommendations in some countries. The current HPV vaccines market is dominated by one major player, Merck’s Gardasil, with GlaxoSmithKline’s (GSK’s) HPV vaccine Cervarix providing the only competition. The introduction of Merck’s nine-valent vaccine (V503) is set to change the future landscape of the HPV vaccines sector.



Research Findings

Global Prophylactic Human Papillomavirus Vaccine Market to Reach $2.2 Billion by 2022, but Access Barriers Must be Overcome, says Publisher

The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate growth over the coming years, climbing from $1.7 billion in 2012 to $2.2 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 2.6%, says a new report from research and consulting firm by Publisher.

The company’s report states that out of the nine major markets (9MM: the US, Canada, France, Germany, Italy, Spain, the UK, Japan and Australia), HPV vaccine sales in Canada and Australia are expected to grow at the largest CAGRs of over 9% during the forecast period.

Publisher believes that Merck’s upcoming nine-valent pipeline vaccine V503 is well placed to capitalize on this need, with sales forecast to reach $1.5 billion in the US alone by 2022, representing a massive 95% market share.



Research Findings Continues..

New nine-valent HPV vaccines are expected to be widely adopted following market approval, stealing market share from existing vaccines. Though a high price represents a potential barrier to market access.

Significant environmental barriers to HPV vaccination exist, which currently serve to limit vaccine uptake.

The emphasis of HPV vaccination is shifting away from an initial focus on cervical cancer prevention in females, towards prevention of a range of cancers in both males and females.

The inclusion of males in routine HPV vaccine recommendations will expand the size of the HPV vaccines market



Report Coverage

1. Introduction2. Disease Overview3. Vaccination Recommendations and Coverage Rates4. Competitive Assessment5. Unmet Need and Opportunity6. Pipeline Assessment7. Current and Future Players8. Market Outlook9. Appendix

For more details regarding Report coverage see the last slide




Company Coverage

1. Merck2. GSK

For more details regarding Report coverage see the last slide




Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/idea-center



How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/ZQP

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/ZQP

http://mrr.cm/ZQP

mailto:[email protected]
